Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with Solid Tumors.

Saved in:
Bibliographic Details
Title: Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with Solid Tumors.
Authors: Yankelevich M; Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA.; Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Hoogstra DJ; Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA.; Helen DeVos Children's Hospital, Division of Pediatric Hematology/Oncology, Grand Rapids, Michigan, USA., Abrams J; Biostatistics Core, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA., Chu R; Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA., Bhambhani K; Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA., Taub JW; Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA.
Source: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2020 Nov; Vol. 37 (8), pp. 665-675. Date of Electronic Publication: 2020 Jul 09.
Publication Type: Clinical Study; Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0669 (Electronic) Linking ISSN: 08880018 NLM ISO Abbreviation: Pediatr Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first